SaTX-1

N/A

Report date: 2024/11/18 10:59:20

Base Information

Drug NameSaTX-1
Drug Alias NameSaTX-1STX-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsProstatic NeoplasmsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStarkAge Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesStarkAge Therapeutics
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A